Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 24, 2019

SELL
$22.08 - $47.08 $11.1 Million - $23.6 Million
-501,818 Closed
0 $0
Q2 2019

Jul 22, 2019

SELL
$22.67 - $35.0 $2.32 Million - $3.58 Million
-102,341 Reduced 16.94%
501,818 $13.9 Million
Q1 2019

Apr 16, 2019

BUY
$26.93 - $34.7 $16.3 Million - $21 Million
604,159 New
604,159 $20.1 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.04B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Sg Capital Management LLC Portfolio

Follow Sg Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Capital Management LLC with notifications on news.